Exact Sciences Corp
NASDAQ:EXAS

Watchlist Manager
Exact Sciences Corp Logo
Exact Sciences Corp
NASDAQ:EXAS
Watchlist
Price: 101.25 USD 0.29% Market Closed
Market Cap: 19.2B USD

Wall Street
Price Targets

EXAS Price Targets Summary
Exact Sciences Corp

Wall Street analysts forecast EXAS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXAS is 100.65 USD with a low forecast of 68.79 USD and a high forecast of 110.25 USD.

Lowest
Price Target
68.79 USD
32% Downside
Average
Price Target
100.65 USD
1% Downside
Highest
Price Target
110.25 USD
9% Upside
Exact Sciences Corp Competitors:
Price Targets
CSL
CSL Ltd
38% Upside
CRNX
Crinetics Pharmaceuticals Inc
71% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
56% Upside
1530
3SBio Inc
37% Upside
LGND
Ligand Pharmaceuticals Inc
30% Upside
ORKA
Oruka Therapeutics Inc
55% Upside
MIRM
Mirum Pharmaceuticals Inc
37% Upside
CPRX
Catalyst Pharmaceuticals Inc
56% Upside

Revenue
Forecast

Revenue Estimate
Exact Sciences Corp

For the last 13 years the compound annual growth rate for Exact Sciences Corp's revenue is 65%. The projected CAGR for the next 3 years is 15%.

65%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Exact Sciences Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Exact Sciences Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-41%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EXAS's stock price target?
Price Target
100.65 USD

According to Wall Street analysts, the average 1-year price target for EXAS is 100.65 USD with a low forecast of 68.79 USD and a high forecast of 110.25 USD.

What is Exact Sciences Corp's Revenue forecast?
Projected CAGR
15%

For the last 13 years the compound annual growth rate for Exact Sciences Corp's revenue is 65%. The projected CAGR for the next 3 years is 15%.

Back to Top